| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,609.5 | 1,477.5 |
| Profit before tax | 257.8 | 219.9 |
| Net income | 149.9 | 126.5 |
| EPS (diluted, $ a share) | $1.50 | $1.24 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +18.5% |
|---|---|
| Revenue, year on year | +8.9% |
10-Q filed with the SEC, NYSE: EHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Encompass Health Corp: key numbers
- Share price
- $137.88Close, Nov 17
- Market cap
- $13.5B
- Shares outstanding
- 98.12MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-HospitalsSIC 8060
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Encompass Health Corp
All →Encompass Health Business Update
Encompass Health announced the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, following catastrophic flooding and patient evacuation on November 1-2, 2026. The company is evaluating options to refurbish or replace the facility with its joint venture partner, Holmes Regional Medical Center. Despite the closure, the company reaffirmed its full-year 2026 financial guidance.
Encompass Health Earnings Call: Key Takeaways
Encompass Health delivered a strong Q3 2026 beat and raised full-year guidance, driven by high-acuity patient mix and effective labor cost management despite regulatory headwinds.
- Call
- Oct 29, 2026, 10:00 AM ET
Encompass Health Financial Results
Encompass Health reported Q3 2026 net operating revenue of $1.61 billion, an 8.9% increase year-over-year, driven by a 5.7% growth in discharges. The company increased its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS following strong performance and the opening of four new hospitals year-to-date.
- Term
- Q3 2026
“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%. During the first nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, reflecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business.”
Mark Tarr, President and Chief Executive Officer